Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma (original) (raw)

• Boye, E. et al. Clonality and altered behavior of endothelial cells from hemangiomas. J. Clin. Invest. 107, 745–752 (2001).
  Article CAS Google Scholar
• Mulliken, J. & Young, A. Vascular Birthmarks: Hemangiomas and Malformations (W. B. Saunders Company, Philadelphia, 1988).
  Google Scholar
• Mulliken, J.B. Cutaneous vascular anomalies. Semin. Vasc. Surg. 6, 204–218 (1993).
  CAS PubMed Google Scholar
• Walter, J.W. et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosom. Cancer 33, 295–303 (2002).
  Article CAS Google Scholar
• North, P.E., Waner, M., Mizeracki, A. & Mihm, M.C., Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum. Pathol. 31, 11–22 (2000).
  Article CAS Google Scholar
• Li, Q., Yu, Y., Bischoff, J., Mulliken, J.B. & Olsen, B.R. Differential expression of CD146 in tissues and endothelial cells derived from infantile hemangiomas and normal human skin. J. Pathol. 201, 296–302 (2003).
  Article CAS Google Scholar
• Barnes, C.M. et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc. Natl. Acad. Sci. USA 102, 19097–19102 (2005).
  Article CAS Google Scholar
• North, P.E. et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch. Dermatol. 137, 559–570 (2001).
  Article CAS Google Scholar
• Chiller, K.G., Passaro, D. & Frieden, I.J. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity and sex. Arch. Dermatol. 138, 1567–1576 (2002).
  Article Google Scholar
• Haggstrom, A.N. et al. Prospective study of infantile hemangiomas: demographic, prenatal and perinatal characteristics. J. Pediatr. 150, 291–294 (2007).
  Article Google Scholar
• Ferrara, N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 94, 209–231 (2005).
  Google Scholar
• Roberts, D.M. et al. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am. J. Pathol. 164, 1531–1535 (2004).
  Article CAS Google Scholar
• Bradley, K.A., Mogridge, J., Mourez, M., Collier, R.J. & Young, J.A. Identification of the cellular receptor for anthrax toxin. Nature 414, 225–229 (2001).
  Article CAS Google Scholar
• Werner, E., Kowalczyk, A.P. & Faundez, V. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J. Biol. Chem. 281, 23227–23236 (2006).
  Article CAS Google Scholar
• Inoue, T. et al. Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16. FEBS Lett. 469, 14–18 (2000).
  Article CAS Google Scholar
• Ito, N., Huang, K. & Claesson-Welsh, L. Signal transduction by VEGF receptor-1 wild type and mutant proteins. Cell. Signal. 13, 849–854 (2001).
  Article CAS Google Scholar
• Wakiya, K., Begue, A., Stehelin, D. & Shibuya, M. A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene. J. Biol. Chem. 271, 30823–30828 (1996).
  Article CAS Google Scholar
• Hogan, P.G., Chen, L., Nardone, J. & Rao, A. Transcriptional regulation by calcium, calcineurin and NFAT. Genes Dev. 17, 2205–2232 (2003).
  Article CAS Google Scholar
• Hesser, B.A. et al. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood 104, 149–158 (2004).
  Article CAS Google Scholar
• Hernandez, G.L. et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J. Exp. Med. 193, 607–620 (2001).
  Article CAS Google Scholar
• Satonaka, H. et al. Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation. Circ. Res. 94, 693–700 (2004).
  Article CAS Google Scholar
• Schwartz, M.A. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J. Cell Biol. 120, 1003–1010 (1993).
  Article CAS Google Scholar
• Leavesley, D.I., Schwartz, M.A., Rosenfeld, M. & Cheresh, D.A. Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol. 121, 163–170 (1993).
  Article CAS Google Scholar
• Jones, N.P., Peak, J., Brader, S., Eccles, S.A. & Katan, M. PLCγ1 is essential for early events in integrin signalling required for cell motility. J. Cell Sci. 118, 2695–2706 (2005).
  Article CAS Google Scholar
• Aplin, A.E., Howe, A., Alahari, S.K. & Juliano, R.L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules and selectins. Pharmacol. Rev. 50, 197–263 (1998).
  CAS PubMed Google Scholar
• Sjaastad, M.D. & Nelson, W.J. Integrin-mediated calcium signaling and regulation of cell adhesion by intracellular calcium. Bioessays 19, 47–55 (1997).
  Article CAS Google Scholar
• Luque, A. et al. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355–425) of the common β1 chain. J. Biol. Chem. 271, 11067–11075 (1996).
  Article CAS Google Scholar
• Schaller, M.D. & Parsons, J.T. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. 6, 705–710 (1994).
  Article CAS Google Scholar
• Guan, J.-L. & Shalloway, D. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358, 690–692 (1992).
  Article CAS Google Scholar
• Abu-Ghazaleh, R., Kabir, J., Jia, H., Lobo, M. & Zachary, I. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861 and migration and anti-apoptosis in endothelial cells. Biochem. J. 360, 255–264 (2001).
  Article CAS Google Scholar
• Blei, F., Walter, J., Orlow, S.J. & Marchuk, D.A. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch. Dermatol. 134, 718–722 (1998).
  Article CAS Google Scholar
• Shinkai, A. et al. Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domain-containing receptor for vascular endothelial growth factor. J. Biol. Chem. 273, 31283–31288 (1998).
  Article CAS Google Scholar
• Kuriyama, M. et al. Activation and translocation of PKCδ is necessary for VEGF-induced ERK activation through KDR in HEK293T cells. Biochem. Biophys. Res. Commun. 325, 843–851 (2004).
  Article CAS Google Scholar
• Sun, Y. et al. The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes. Blood 107, 1476–1483 (2006).
  Article CAS Google Scholar
• Shenoy, P.S. et al. beta1 Integrin-extracellular matrix protein interaction modulates the migratory response to chemokine stimulation. Biochem. Cell Biol. 79, 399–407 (2001).
  Article CAS Google Scholar
• Vikkula, M. et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87, 1181–1190 (1996).
  Article CAS Google Scholar
• Brouillard, P. et al. Four common glomulin mutations cause two thirds of glomuvenous malformations (“familial glomangiomas”): evidence for a founder effect. J. Med. Genet. 42, e13 (2005).
  Article CAS Google Scholar
• North, P.E., Waner, M., Buckmiller, L., James, C.A. & Mihm, M.C. Jr. Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc. Pathol. 15, 303–317 (2006).
  Article Google Scholar
• Ritter, M.R., Reinisch, J., Friedlander, S.F. & Friedlander, M. Myeloid cells in infantile hemangioma. Am. J. Pathol. 168, 621–628 (2006).
  Article Google Scholar
• Takahashi, K. et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J. Clin. Invest. 93, 2357–2364 (1994).
  Article CAS Google Scholar
• Razon, M.J., Kräling, B.M., Mulliken, J.B. & Bischoff, J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation 5, 189–195 (1998).
  Article CAS Google Scholar
• Akuzawa, N., Kurabayashi, M., Ohyama, Y., Arai, M. & Nagai, R. Zinc finger transcription factor Egr-1 activates Flt-1 gene expression in THP-1 cells on induction for macrophage differentiation. Arterioscler. Thromb. Vasc. Biol. 20, 377–384 (2000).
  Article CAS Google Scholar
• Fragoso, R. et al. VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease. Blood 107, 1608–1616 (2006).
  Article CAS Google Scholar
• Claesson-Welsh, L. Signal transduction by vascular endothelial growth factor receptors. Biochem. Soc. Trans. 31, 20–24 (2003).
  Article CAS Google Scholar
• Liu, S. & Leppla, S.H. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation and internalization. J. Biol. Chem. 278, 5227–5234 (2003).
  Article CAS Google Scholar
• Kitamura, T. et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31, 1007–1014 (2003).
  Article CAS Google Scholar
• Khan, Z.A. et al. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 108, 915–921 (2006).
  Article CAS Google Scholar
• Picard, A. et al. IFG-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr. Res. 63, 263–267 (2008).
  Article Google Scholar